Using Cost-Effectiveness Evidence to Inform Decisions as to which Health Services to Provide
Author:
Open Access
- 2 January 2016
- journal article
- research article
- Published by Taylor & Francis in Health Systems & Reform
- Vol. 2 (1) , 32-38
Abstract
—This article focuses on three challenges concerning the use of cost-effectiveness thresholds to inform decision making regarding which services a third-party payer will fund. First, how is the appropriate cost-effectiveness threshold or threshold range to be determined or, indeed, should there be a single threshold or multiple thresholds? Second, how can the valuation of health benefits be refined to better capture the value of treatments to patients and to the economy as a whole? Third, how is the tension between cost-effectiveness and the affordability and sustainability of health services to be managed?It concludes that whatever other factors are considered in addition to cost-effectiveness, and whether the decision-making process is more or less deliberative, cost-effectiveness thresholds are important. Though there is a range of sources for identifying appropriate thresholds, using the opportunity cost in terms of the health benefits from displaced activities will minimize the problem of cost-effective interventions not being affordable and will facilitate the efficient use of scarce resources. Finally, although experience using weighted quality-adjusted life years (QALYs) is currently very limited, it is likely to be an important area in the future.Keywords
This publication has 12 references indexed in Scilit:
- Methods for the estimation of the National Institute for Health and Care Excellence cost-effectiveness thresholdHealth Technology Assessment, 2015
- The Influence of Cost‐Effectiveness and Other Factors on Nice DecisionsHealth Economics, 2014
- The Willingness to Pay for a Quality Adjusted Life Year: A Review of the Empirical LiteratureHealth Economics, 2014
- Are Current Cost-Effectiveness Thresholds for Low- and Middle-Income Countries Useful? Examples from the World of VaccinesPharmacoEconomics, 2014
- Multiple Criteria Decision Analysis for Health Technology AssessmentValue in Health, 2012
- Evidence and values: paying for end-of-life drugs in the British NHSHealth Economics, Policy and Law, 2012
- Priority-Setting Institutions in Health: Recommendations from a Center for Global Development Working GroupGlobal Heart, 2012
- Balancing equity and efficiency in the Dutch basic benefits package using the principle of proportional shortfallThe European Journal of Health Economics, 2011
- The NICE Cost-Effectiveness ThresholdPharmacoEconomics, 2008
- Searching for a threshold, not setting one: the role of the National Institute for Health and Clinical ExcellenceJournal of Health Services Research & Policy, 2007